AstraZeneca ups profit outlook on strong cancer drugs demand
By Maggie Fick and Eva Mathews LONDON (Reuters) -AstraZeneca raised its annual earnings forecast on Thursday, helped by strong demand
1970-01-01 08:00
AstraZeneca to pay $425 million to settle Nexium, Prilosec litigation in US
British drugmaker AstraZeneca on Tuesday said it will pay $425 million to settle product liability litigations related to
1970-01-01 08:00
AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims
By Daniel Wiessner AstraZeneca Pharmaceuticals LP has been sued in the U.S. by a former senior director who
1970-01-01 08:00
AstraZeneca's Tagrisso-chemo combo results raise bar for J&J cancer drug-analysts
By Maggie Fick LONDON Data released on Monday by AstraZeneca from a late-stage trial combining its blockbuster cancer
1970-01-01 08:00
AstraZeneca files litigation to challenge Inflation Reduction Act
British drugmaker AstraZeneca said on Friday it has filed a legal challenge to critical aspects of a program
1970-01-01 08:00
AstraZeneca to buy Pfizer's rare disease gene therapy portfolio for up to $1 billion
(Reuters) -AstraZeneca said on Friday its unit Alexion has agreed to buy U.S. drugmaker Pfizer's early-stage rare disease gene therapy
1970-01-01 08:00
AstraZeneca planning China business spin off -FT
Drugmaker AstraZeneca is drafting a plan to spin off its China business, and listing a separate unit in
1970-01-01 08:00
AstraZeneca drug combo gets US nod to treat a type of prostate cancer
AstraZeneca said on Thursday that a combination of its cancer drug Lynparza and abiraterone has been approved in
1970-01-01 08:00